Literature DB >> 6276544

Inhibition of separated forms of cyclic nucleotide phosphodiesterase from pig coronary arteries by 1,3-disubstituted and 1,3,8-trisubstituted xanthines.

J N Wells, J E Garst, G L Kramer.   

Abstract

A series of xanthines with varied substituents in the 1, 3, and 8 positions were prepared in an attempt to understand the structure--activity relationship for alkylxanthines as inhibitors of two different forms of cyclic nucleotide phosphodiesterase. Polar substituents on the 1 or 3 position of the xanthine reduced the potency of the xanthines to inhibit both the calmodulin-sensitive and the "cyclic AMP specific" forms of phosphodiesterase. Polar substituents on the 8 position of the xanthine, other than a carboxylic acid, increased the potency to inhibit the calmodulin-sensitive form of phosphodiesterase, if they were capable of donating electrons to the xanthine nucleus. On the other hand, any substituent in the 8 position larger than H reduced the potency of the xanthines to inhibit the cyclic AMP specific form of phosphodiesterase. Topographical maps of the active sites of the two forms of phosphodiesterase are presented in summary.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6276544     DOI: 10.1021/jm00140a008

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  3 in total

1.  Inhibitors of cyclic nucleotide phosphodiesterase isozymes type-III and type-IV suppress mitogenesis of rat mesangial cells.

Authors:  K Matousovic; J P Grande; C C Chini; E N Chini; T P Dousa
Journal:  J Clin Invest       Date:  1995-07       Impact factor: 14.808

2.  Caffeine analogs: effects on ryanodine-sensitive calcium-release channels and GABAA receptors.

Authors:  Dan Shi; William L Padgett; John W Daly
Journal:  Cell Mol Neurobiol       Date:  2003-06       Impact factor: 5.046

3.  Role of selective cyclic GMP phosphodiesterase inhibition in the myorelaxant actions of M&B 22,948, MY-5445, vinpocetine and 1-methyl-3-isobutyl-8-(methylamino)xanthine.

Authors:  J E Souness; R Brazdil; B K Diocee; R Jordan
Journal:  Br J Pharmacol       Date:  1989-11       Impact factor: 8.739

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.